Lymphangiogenesis: in vitro and in vivo models

被引:71
作者
Bruyere, Francoise [1 ]
Noel, Agnes [1 ]
机构
[1] Univ Liege, Lab Tumor & Dev Biol, GIGA Canc, CHU Sart Tilman B23, B-4000 Liege, Belgium
关键词
lymphatic endothelial cell; lymphedema; metastatic dissemination; graft rejection; LYMPHATIC ENDOTHELIAL-CELLS; GROWTH-FACTOR-C; VEGF-C; NODE METASTASIS; INTERSTITIAL FLOW; TUMOR LYMPHANGIOGENESIS; FACTOR RECEPTOR-3; THORACIC-DUCT; GENE-THERAPY; INTRATUMORAL LYMPHANGIOGENESIS;
D O I
10.1096/fj.09-132852
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lymphangiogenesis, the formation of new lymphatic vessels from preexisting ones, is an important biological process associated with diverse pathologies, such as metastatic dissemination and graft rejection. In addition, lymphatic hypoplasia characterizes lymphedema, usually a progressive and lifelong condition for which no curative treatment exists. Much progress has been made in recent years in identifying molecules specifically expressed on lymphatic vessels and in the setting up of in vitro and in vivo models of lymphangiogenesis. These new tools rapidly provided an abundance of information on the mechanisms underlying lymphatic development and the progression of diseases associated with lymphatic dysfunction. In this review, we describe the common in vitro and in vivo models of lymphangiogenesis that have proven suitable for investigating lymphatic biology and the interactions occurring between lymphatic vessels and other cells, such as immune cells and cancer cells. Their rationales and limitations are discussed and illustrated by the most informative findings obtained with them.-Bruyere, F., Noel, A. Lymphangiogenesis: in vitro and in vivo models. FASEB J. 24, 8 - 21 (2010). www.fasebj.org
引用
收藏
页码:8 / 21
页数:14
相关论文
共 194 条
  • [1] Molecular control of lymphatic metastasis
    Achen, Marc G.
    Stacker, Steven A.
    [J]. LYMPHATIC CONTINUUM REVISITED, 2008, 1131 : 225 - 234
  • [2] Molecular regulation of angiogenesis and lymphangiogenesis
    Adams, Ralf H.
    Alitalo, Kari
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (06) : 464 - 478
  • [3] Alajati A, 2008, NAT METHODS, V5, P439, DOI [10.1038/nmeth.1198, 10.1038/NMETH.1198]
  • [4] Blood and lymphatic endothelial cell-specific differentiation programs are stringently controlled by the tissue environment
    Amatschek, Stefan
    Kriehuber, Ernst
    Bauer, Wolfgang
    Reininger, Barbel
    Meraner, Paul
    Wolpl, Alois
    Schweifer, Norbert
    Haslinger, Christian
    Stingl, Georg
    Maurer, Dieter
    [J]. BLOOD, 2007, 109 (11) : 4777 - 4785
  • [5] Ando T., 2005, Lymphatic Research and Biology, V3, P105, DOI 10.1089/lrb.2005.3.105
  • [6] Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1
    Ayadi, A
    Zheng, H
    Sobieszczuk, P
    Buchwalter, G
    Moerman, P
    Alitalo, K
    Wasylyk, B
    [J]. EMBO JOURNAL, 2001, 20 (18) : 5139 - 5152
  • [7] Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation
    Baluk, P
    Tammela, T
    Ator, E
    Lyubynska, N
    Achen, MG
    Hicklin, DJ
    Jeltsch, M
    Petrova, TV
    Pytowski, B
    Stacker, SA
    Ylä-Herttuala, S
    Jackson, DG
    Alitalo, K
    McDonald, DM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) : 247 - 257
  • [8] Markers for microscopic imaging of lymphangiogenesis and angiogenesis
    Baluk, Peter
    McDonald, Donald M.
    [J]. LYMPHATIC CONTINUUM REVISITED, 2008, 1131 : 1 - 12
  • [9] Growth hormone promotes lymphangiogenesis
    Banziger-Tobler, Nadja Erika
    Halin, Cornelia
    Kajiya, Kentaro
    Detmar, Michael
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2008, 173 (02) : 586 - 597
  • [10] Berndt Sarah, 2008, P305, DOI 10.1007/978-0-387-69057-5_16